4-hydroxy-2-nonenal and Cochlear-Diseases

4-hydroxy-2-nonenal has been researched along with Cochlear-Diseases* in 1 studies

Other Studies

1 other study(ies) available for 4-hydroxy-2-nonenal and Cochlear-Diseases

ArticleYear
Triamcinolone acetonide protects auditory hair cells from 4-hydroxy-2,3-nonenal (HNE) ototoxicity in vitro.
    Acta oto-laryngologica, 2006, Volume: 126, Issue:7

    Triamcinolone acetonide crystalline suspension (e.g. Volon A) was not ototoxic to the auditory hair cells present within organ of Corti explants and protected them from an ototoxic molecule, i.e. 4-hydroxy-2,3-nonenal (HNE), that is produced within the organ of Corti as a result of oxidative stress-induced damage.. To test the corticosteroid, triamcinolone acetonide, for ototoxicity and otoprotective capacity in organ of Corti explants.. Organ of Corti explants excised from 4-day-old rats were the test system, HNE was the ototoxin challenge. Hair cell integrity counts were performed with fluorescent microscopy on fixed explants stained with FITC-labeled phalloidin. Statistical significance was set at p<0.05.. Triamcinolone acetonide did not affect hair cell integrity in the organ of Corti explants and it provided a high level of protection of hair cells against the ototoxic effects of a damaging level of HNE as determined by hair cell density counts.

    Topics: Aldehydes; Animals; Cochlear Diseases; Glucocorticoids; Hair Cells, Auditory; In Vitro Techniques; Organ of Corti; Oxidative Stress; Rats; Rats, Sprague-Dawley; Triamcinolone Acetonide

2006